Aileron Therapeutics is a biotechnology company focused on the development of innovative drug therapies that leverage its proprietary platform for the design of stapled peptides
These therapies are aimed at treating a range of serious diseases, including cancer and other conditions characterized by protein-protein interactions. By stabilizing the structure of peptides, the company enhances their ability to engage specific biological targets, with the goal of improving patient outcomes through more effective treatments. Aileron's commitment to advancing therapeutic options is supported by robust research and collaborations within the scientific community.
Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to enhance lung function in IPF patients.
Shares of United Parcel Service, Inc. (NYSEUPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales
Shares of Quanex Building Products Corporation (NYSENX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.
Shares of Getaround, Inc. (NYSEGETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.
Aileron Therapeutics's (NASDAQALRN) short percent of float has risen 50.0% since its last report. The company recently reported that it has 30 thousand shares sold short, which is 0.84% of all regular shares that are available for trading.
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 2% on Tuesday. The Dow traded down 2.06% to 33,129.04 while the NASDAQ fell 2.39% to 11,506.10. The S&P 500 also fell, dropping, 2.05% to 3,995.66.
Gainers Arbe Robotics Ltd. (NASDAQARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
